The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
Open accessAbstract
The cellular hallmarks of Parkinson's disease (PD) are the loss of nigral dopaminergic neurons and the formation of α-synuclein-enriched Lewy bodies and Lewy neurites in the remaining neurons. Based on the topographic distribution of Lewy bodies established after autopsy of brains from PD patients, Braak and coworkers hypothesized that Lewy pathology primes in the enteric nervous system and spreads to the brain, suggesting an active retrograde transport of α-synuclein (the key protein component in Lewy bodies), via the vagal nerve. This hypothesis, however, has not been tested experimentally thus far. Here, we use a human PD brain lysate containing different forms of α-synuclein (monomeric, oligomeric and fibrillar), and recombinant α-synuclein in an in vivo animal model to test this hypothesis. We demonstrate that α-synuclein present in the human PD brain lysate and distinct recombinant α-synuclein forms are transported via the vagal nerve and reach the dorsal motor nucleus of the vagus in the brainstem in a time-dependent manner after injection into the intestinal wall. Using live cell imaging in a differentiated neuroblastoma cell line, we determine that both slow and fast components of axonal transport are involved in the transport of aggregated α-synuclein. In conclusion, we here provide the first experimental evidence that different α-synuclein forms can propagate from the gut to the brain, and that microtubule-associated transport is involved in the translocation of aggregated α-synuclein in neurons.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Third, cellular and animal studies have provided a model for prion-like spread of α-synuclein from the gut to the brain via the enteric nervous system, chiefly through the vagus nerve [15–17].”
From The gut–brain axis in early Parkinson’s disease: from prodrome to prevention (2025) · cites this paper as [17]
In the citing paper
“Involvement of the vagal nerve in the propagation of α-synuclein from the gut to the brain was demonstrated by Holmqvist et al. [399].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [399]
In the citing paper
“In accordance with this hypothesis it has been shown that alphasynuclein can be retrogradely transported from the intestinal wall to the brain in rats (Holmqvist et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Holmqvist et al., 2014
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Mobility measurement by analysis of fluorescence photobleaching recovery kinetics
Axelrod, D., Koppel, D. E., Schlessinger, J., Elson, E. L., & Webb, W. W. (1976) · Biophysical Journal · doi:10.1016/s0006-3495(76)85755-4 · Cited by 2,717
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Self-citationLewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
In vivo demonstration that α-synuclein oligomers are toxic
Winner, B., Jappelli, R., Maji, S. K., Desplats, P. A., Boyer, L., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100976108 · Cited by 1,463
Cited by
Sorted by citations
Items 901–925 of 925
Mook‐Jung, I. (2026) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2026.103234
Cheng, Y.-K., & Chiang, H.-S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40306-4.00004-1
Walter, U., Batchakaschvili, M., Kleinlein, H. R., Radziwon, J., Hermann, W., Walter, H., Storch, A., & Löhle, M. (2026) · Journal of Neurology · doi:10.1007/s00415-026-13973-0
Sharma, S. A., & Patri, M. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01924-7
New horizons in HIV neuropathogenesis: thinking beyond the brain
Angelovich, T. A., Busman‐Sahay, K., Eddine, J. J., Churchill, M. J., Okoye, A. A., & Estes, J. D. (2026) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000001052
Wang, M., Sun, G., Wan, P., Wang, Z., Nie, Y., Liu, H., Geng, M., Liu, M., & Zhang, Y. (2026) · Brain Sciences · doi:10.3390/brainsci16080804
Self-citationAnatomy and function of efferent and afferent vagal innervation of the stomach
Berthoud, H., Münzberg, H., Yu, S., Morrison, C. D., Kim, A., & Neuhuber, W. (2026) · Autonomic Neuroscience · doi:10.1016/j.autneu.2026.103465
Gut microbiota-derived extracellular vesicles in Parkinson’s disease
Salmi, S., Tejesvi, M. V., Hekkala, J., Turunen, J., Kaisanlahti, A., Virtanen, N., Mishra, S., Zhyvolozhnyi, A., Sinkkonen, N., Suokas, M., et al. (2026) · iScience · doi:10.1016/j.isci.2026.117057
Balsamo, J. M., & Bess, E. N. (2026) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.6c00110
Targeting Aberrant Protein-Protein Interactions in Cancer and Neurodegenerative Diseases
Ball, T. D. (2025) · Digital Commons - DU (University of Denver) · doi:10.56902/etdcrp.2025.222
The therapeutic potential of saponins for neurological diseases via the gut-brain axis
Wang, X., Li, S., Zhong, G., Zhang, T., Chen, Q., Jing, S., Liu, S., Liu, J., & Wang, Q. (2026) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(26)61203-4
Overlapping pathologies in different dementia-causing diseases
Spires‐Jones, T. L. (2026) · Oxford University Press eBooks · doi:10.1093/9780198995296.003.0004
Gastrointestinal manifestations of Parkinson's disease
Pfeiffer, R. F., & Quigley, E. M. M. (2026) · Autonomic Neuroscience · doi:10.1016/j.autneu.2026.103475
Sequential Molecular Interactions Shape Aβ42 Aggregation, Propagation, and ToxicityPreprint
Curto, J. S., Collell, G. P., Ruiz, M., Villegas, S., Fernández, M. R., & de Groot, N. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.27.747468
Jena, S., Subham, K., Kalra, H., Naik, S., Sahu, D. D., Mishra, M., & Jha, S. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.154365
Ultrastructural perspectives on the enteric nervous system in Parkinson’s disease
Lappe, F., Heinen‐Weiler, J., Stahlke, S., & Theiß, C. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1927448
Microbiome and Diseases: Gut–Brain Axis and Neurological Disorders
de Castilhos, J., & Stein‐Thoeringer, C. K. (2026) · Springer eBooks · doi:10.1007/978-3-032-26410-7_18
Han, Y., Shen, L., Chen, L., Chen, H., Hu, W., Yu, C., & Wang, W. (2026) · Journal of Future Foods · doi:10.1016/j.jfutfo.2026.09.008
Mingke, T., Li, J., Zhang, C., Tu, R., & Wang, S. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1973833
Self-citationDDX39A unwinds viral RNA G-quadruplexes to limit α-Synuclein amyloidogenesis
Jain, A., Tripathi, S., Agarwal, C., Biswas, A., Potharaju, P. S., De, A., Mansuri, S., Mondal, A., Harshan, K. H., & Raychaudhuri, S. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.118060
Bowler, B., Nasir, A. R., Szewczyk, A., Ocañas, S. R., Unnikrishnan, A., & Nouh, C. D. (2026) · Pathophysiology · doi:10.3390/pathophysiology33040074
The microbiota–proteostasis axis: implications in neurodegenerative diseases
Czyż, D. M., & Brown, B. M. (2026) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2025.0265
Emergent therapeutic agents in the treatment of Parkinson's disease
Khafaga, D. S. R., Abdelhadi, E. K., Farouk, Z. E., Aswa, D. W., Elhendawy, A. T., Ghazi, A. M., Selim, R. N., Al-Namrouti, A. T., Elgayar, E. A., El-Morsy, M. T., et al. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27702-3.00022-4
Emerging links between gut dysbiosis, aryl hydrocarbon receptor activation, and Parkinson’s disease
Aziz, N. F., & Kortagere, S. (2026) · Communications Biology · doi:10.1038/s42003-026-11156-1
The role of gut microbiota in Parkinson's disease pharmacotherapy
Wadan, A. S., Hammadeh, B. M., Ahmed, M. A., Maged, A. A., & Ellakwa, D. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-54032-5.00002-4
Metadata
- Authors
- Holmqvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Björklund, T., Wang, Z.-Y., Roybon, L., Melki, R., & Li, J.-Y.
- Affiliations
- Lund University (SE)
- Centre National de la Recherche Scientifique (FR)
- Northeastern University (CN)
- ORCID
- Venue
- Acta Neuropathologica
- Published
- 2014-10-09
- Volume
- 128
- Issue
- 6
- Pages
- 805-820
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W1995281235
- Cited by
- 925
- References
- 51
- Citations by year
- 2026: 47 · 2025: 67 · 2024: 73 · 2023: 67 · 2022: 110 · 2021: 132 · 2020: 102 · 2019: 107 · 2018: 75 · 2017: 59 · 2016: 43 · 2015: 38 · 2014: 3
- FWCI
- 30.94
- Type
- journal article
- Language
- en
- Open access
- green
- lup.lub.lu.se
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- Funders
- Agence Nationale de la Recherche (ANR-11-BSV8-0021)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, alpha-synuclein, Lewy bodies, gut-brain axis, vagus nerve, retrograde transport, enteric nervous system, dorsal motor nucleus of the vagus, axonal transport, alpha-synuclein aggregation, rat model
- MeSH terms
- Animals, Axonal Transport, Brain, Disease Models, Animal, Humans, Parkinson Disease, Recombinant Proteins, Vagus Nerve, Rats, Sprague-Dawley, Disease Progression, Gastrointestinal Tract, Cell Line, Tumor, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
